Patient & Visitor Alert: Because flu cases are on the rise, starting February 24, children 12 and younger will be restricted from visiting hospitals and certain inpatient facilities throughout Carolinas HealthCare System. Learn more.
This study aims to determine if treatment with apixaban, compared with aspirin, will reduce the risk of schemic stroke and systemic embolism in patients with device-detected sub-clinical atrial fibrillation (SCAF) and additional risk factors for stroke.
Who may be Eligible
Patients with a permanent pacemaker or defibrillator or insertable cardiac monitor capable of detecting SCAF, with at least one episode of SCAF lasting at least 6 minutes but not more than 24 hours.